Novavax still plans to push RSV vaccine to market after failed trial

Washington Business Journal

Jun 10, 2019

It's official: Novavax Inc. will have to complete another clinical trial for its respiratory syncytial virus vaccine candidate for infants, ResVax, lengthening its road to market b…